Latest stories on PHAT
PHAT Stock Falls 7% As Leerink Sees Little Near-Term Upside — CEO Plays Down Upcoming Rival
Stocktwits News38 · neutralanalyst
Phathom Pharmaceuticals: Specialist Economics Strengthens The Bull Case
Seeking Alpha63 · neutralproduct/pr
Leerink starts Phathom Pharmaceuticals at Market Perform on limited upside
The Fly51 · neutralanalyst
Phathom Pharmaceuticals initiated with a Market Perform at Leerink
The Fly56 · neutralanalyst
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
GlobeNewswire56 · neutralgeneral
Phathom Pharmaceuticals price target lowered to $14 from $18 at Barclays
The Fly34 · bearishanalyst
Phathom Pharmaceuticals, Inc. 2026 Q2 - Results - Earnings Call Presentation
Seeking Alpha50 · neutralearnings
Phathom forecasts $310M-$325M 2026 revenue while planning Phase 3 as-needed GERD trial in Q4
Seeking Alpha63 · neutralproduct/pr
Phathom Pharmaceuticals, Inc. (PHAT) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
PHAT Stock Clocks Worst Day In Over 1.5 Years — What Sparked The Selloff?
Stocktwits News32 · bearishgeneral
Guggenheim cuts Phathom Pharmaceuticals price target on guidance reduction
Investing.com Analyst Ratings34 · bearishanalyst
Phathom Pharmaceuticals Achieves Record Revenue, Operating Profitability, and Major Pipeline Progress in Q2 2026
July 30, 2026
MarketChameleon73 · bullishearnings
Phathom Pharmaceuticals Non-GAAP EPS of $0.00 beats by $0.10, revenue of $74.27M beats by $1.58M
Seeking Alpha68 · bullishearnings
Phathom Pharmaceuticals, Inc. (PHAT) files 8-K
SEC 8-K50 · neutralgeneral
Phathom Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
StockTitan50 · neutralearnings
Phathom Completes Enrollment in Eosinophilic Esophagitis Trial
TipRanks63 · neutralproduct/pr
Phathom Pharmaceuticals, Inc. (PHAT) files 8-K
SEC 8-K50 · neutralgeneral
Phathom Pharmaceuticals, Inc. (PHAT) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Seeking Alpha56 · neutralgeneral
Phathom: Why I'm Downgrading To "Sell" Ahead Of Competition
Seeking Alpha32 · bearishanalyst
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences | PHAT Stock News
StockTitan55 · neutralgeneral
Phathom Shareholders Reaffirm Board, Pay and Auditor
TipRanks50 · neutralgeneral